155 related articles for article (PubMed ID: 38061444)
1. TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases.
Nocco SE; Ewalt MD; Moy AP; Lewis NE; Zhu M; Lezcano C; Busam K; Pulitzer M
J Am Acad Dermatol; 2024 Apr; 90(4):839-841. PubMed ID: 38061444
[No Abstract] [Full Text] [Related]
2. T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders.
Pulitzer M; Geller S; Kumar E; Frosina D; Moskowitz A; Horwitz S; Myskowski P; Kheterpal M; Chan A; Dogan A; Jungbluth A
Histopathology; 2018 Oct; 73(4):653-662. PubMed ID: 29893430
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
Wood GS
Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
[TBL] [Abstract][Full Text] [Related]
4. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
[TBL] [Abstract][Full Text] [Related]
5. Utility of TRBC1 Expression in the Diagnosis of Peripheral Blood Involvement by Cutaneous T-Cell Lymphoma.
Horna P; Shi M; Jevremovic D; Craig FE; Comfere NI; Olteanu H
J Invest Dermatol; 2021 Apr; 141(4):821-829.e2. PubMed ID: 33049270
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous T-cell lymphoma at a young age.
Roszkiewicz J; Roszkiewicz A; Wojdylo M; Placek W; Jasiel-Walikowska E
Cutis; 2001 Mar; 67(3):197-200, 203-4. PubMed ID: 11270292
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the γδ phenotype from Japan.
Takahashi Y; Takata K; Kato S; Sato Y; Asano N; Ogino T; Hashimoto K; Tashiro Y; Takeuchi S; Masunari T; Hiramatsu Y; Maeda Y; Tanimoto M; Yoshino T
Cancer Sci; 2014 Jul; 105(7):912-23. PubMed ID: 24815502
[TBL] [Abstract][Full Text] [Related]
9. TRBC1 expression assessed by flow cytometry as a novel marker of clonality in cutaneous αβ T-cell lymphomas with peripheral blood involvement.
Martin-Moro F; Martin-Rubio I; Garcia-Vela JA
Br J Dermatol; 2022 Oct; 187(4):623-625. PubMed ID: 35606929
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-Associated B-Cell Lymphoproliferative Disease in a Patient With Cutaneous T-Cell Lymphoma.
Maderal AD; Malone JC; Callen JP
JAMA Dermatol; 2018 Apr; 154(4):490-492. PubMed ID: 29490369
[No Abstract] [Full Text] [Related]
11. Primary cutaneous angioimmunoblastic T-cell lymphoma histologically mimicking an inflammatory dermatosis.
Smithberger ES; Rezania D; Chavan RN; Lien MH; Cualing HD; Messina JL
J Drugs Dermatol; 2010 Jul; 9(7):851-5. PubMed ID: 20677543
[TBL] [Abstract][Full Text] [Related]
12. Necrobiotic cutaneous T-cell lymphoma.
Woollons A; Darvay A; Khorshid SM; Whittaker S; Jones RR
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):815-9. PubMed ID: 10534657
[TBL] [Abstract][Full Text] [Related]
13. New insights into the applicability of T-cell receptor gamma gene rearrangement analysis in cutaneous T-cell lymphoma.
Li N; Bhawan J
J Cutan Pathol; 2001 Sep; 28(8):412-8. PubMed ID: 11493379
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR/DGGE)-based detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded cutaneous biopsies in cutaneous T-cell lymphoproliferative diseases.
Andersen WK; Li N; Bhawan J
J Cutan Pathol; 1999 Apr; 26(4):176-82. PubMed ID: 10335894
[TBL] [Abstract][Full Text] [Related]
15. Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T‑cell lymphoma.
Gibbs JD; Ma S; Kim A; Seminario-Vidal L; Sokol L; Zhang H; Zhang X; Sagatys E; Chen PL; Messina JL
Oncol Rep; 2021 Jan; 45(1):349-358. PubMed ID: 33416132
[TBL] [Abstract][Full Text] [Related]
16. Clinical, histopathological, immunophenotypic and molecular analysis of 60 patients with cutaneous T-cell infiltrates with follow up of indeterminate cases to identify T-cell lymphoma.
Eros N; Károlyi Z; Marschalkó M; Kárpáti S; Matolcsy A
Pathol Oncol Res; 2008 Mar; 14(1):63-7. PubMed ID: 18392954
[TBL] [Abstract][Full Text] [Related]
17. CD8-positive primary cutaneous peripheral T-cell lymphoma, unspecified.
Rosmaninho A; Sanches M; Alves R; Lima M; Selores M
Eur J Dermatol; 2012; 22(1):131-2. PubMed ID: 22062773
[No Abstract] [Full Text] [Related]
18. Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2.
Wasik MA; Sackstein R; Novick D; Butmarc JR; Zhang Q; Vonderheid EC; Kadin ME
Hum Pathol; 1996 Jul; 27(7):738-44. PubMed ID: 8698322
[TBL] [Abstract][Full Text] [Related]
19. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas.
Wobser M; Roth S; Reinartz T; Rosenwald A; Goebeler M; Geissinger E
Br J Dermatol; 2015 Jun; 172(6):1573-1580. PubMed ID: 25524664
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis.
Hu T; Krejsgaard T; Nastasi C; Buus TB; Nansen A; Hald A; Spee P; Nielsen PR; Blümel E; Gluud M; Willerslev-Olsen A; Woetmann A; Bzorek M; Eriksen JO; Ødum N; Rahbek Gjerdrum LM
Dermatology; 2020; 236(2):123-132. PubMed ID: 31536992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]